Biopsy-verified response of severe lupus nephritis to treatment with rituximab (anti-CD20 monoclonal antibody) plus cyclophosphamide after biopsy-documented failure to respond to cyclophosphamide alone

By Vollenhoven RF van   Gunnarsson I   Welin-Henriksson E   Sundelin B   Österborg A   Jacobson SH   Klareskog L  

Scandinavian Journal of Rheumatology, Vol. 33, Iss. 6, 2004-11 ,pp. : 423-427

Informa Healthcare

Access to resources Recommend Favorite

Safety and efficacy of combined cyclophosphamide and rituximab treatment in recalcitrant childhood lupus

By AlE’ed Ashwaq   AlSonbul Abdullah   Al-Mayouf Sulaiman  

Rheumatology International, Vol. 34, Iss. 4, 2014-04 ,pp. : 529-533

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of repeat courses of rituximab treatment in patients with severe refractory juvenile idiopathic arthritis

By Alexeeva Ekaterina   Valieva Saniya   Bzarova Tatyana   Semikina Elena   Isaeva Kseniya   Lisitsyn Alexander   Denisova Rina   Chistyakova Evgeniya  

Clinical Rheumatology, Vol. 30, Iss. 9, 2011-09 ,pp. : 1163-1172

Springer Publishing Company

Access to resources Recommend Favorite

Update on the Therapies of Severe Lupus Nephritis

By  

Current Rheumatology Reviews, Vol. 2, Iss. 2, 2006-05 ,pp. : 186-190

Bentham Science Publishers

Access to resources Recommend Favorite

Successful treatment of Sjogren's syndrome with rituximab

By Touma Z.   Sayad J.   Arayssi T.  

Scandinavian Journal of Rheumatology, Vol. 35, Iss. 4, 2006-07 ,pp. : 323-325

Informa Healthcare

Access to resources Recommend Favorite